These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

798 related items for PubMed ID: 15486831

  • 1. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
    Walsh DS, Wilairatana P, Tang DB, Heppner DG, Brewer TG, Krudsood S, Silachamroon U, Phumratanaprapin W, Siriyanonda D, Looareesuwan S.
    Clin Infect Dis; 2004 Oct 15; 39(8):1095-103. PubMed ID: 15486831
    [Abstract] [Full Text] [Related]

  • 2. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.
    Llanos-Cuentas A, Lacerda MV, Rueangweerayut R, Krudsood S, Gupta SK, Kochar SK, Arthur P, Chuenchom N, Möhrle JJ, Duparc S, Ugwuegbulam C, Kleim JP, Carter N, Green JA, Kellam L.
    Lancet; 2014 Mar 22; 383(9922):1049-58. PubMed ID: 24360369
    [Abstract] [Full Text] [Related]

  • 3. Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand.
    Walsh DS, Looareesuwan S, Wilairatana P, Heppner DG, Tang DB, Brewer TG, Chokejindachai W, Viriyavejakul P, Kyle DE, Milhous WK, Schuster BG, Horton J, Braitman DJ, Brueckner RP.
    J Infect Dis; 1999 Oct 22; 180(4):1282-7. PubMed ID: 10479159
    [Abstract] [Full Text] [Related]

  • 4. Tafenoquine for the treatment of recurrent Plasmodium vivax malaria.
    Kitchener S, Nasveld P, Edstein MD.
    Am J Trop Med Hyg; 2007 Mar 22; 76(3):494-6. PubMed ID: 17360873
    [Abstract] [Full Text] [Related]

  • 5. The efficacy and tolerability of three different regimens of tafenoquine versus primaquine for post-exposure prophylaxis of Plasmodium vivax malaria in the Southwest Pacific.
    Elmes NJ, Nasveld PE, Kitchener SJ, Kocisko DA, Edstein MD.
    Trans R Soc Trop Med Hyg; 2008 Nov 22; 102(11):1095-101. PubMed ID: 18541280
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping.
    Beck HP, Wampfler R, Carter N, Koh G, Osorio L, Rueangweerayut R, Krudsood S, Lacerda MV, Llanos-Cuentas A, Duparc S, Rubio JP, Green JA.
    J Infect Dis; 2016 Mar 01; 213(5):794-9. PubMed ID: 26500351
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia.
    Alvarez G, Piñeros JG, Tobón A, Ríos A, Maestre A, Blair S, Carmona-Fonseca J.
    Am J Trop Med Hyg; 2006 Oct 01; 75(4):605-9. PubMed ID: 17038680
    [Abstract] [Full Text] [Related]

  • 9. Operational effectiveness of tafenoquine and primaquine for the prevention of Plasmodium vivax recurrence in Brazil: a retrospective observational study.
    Brito M, Rufatto R, Brito-Sousa JD, Murta F, Sampaio V, Balieiro P, Baía-Silva D, Castro V, Alves B, Alencar A, Duparc S, Grewal Daumerie P, Borghini-Fuhrer I, Jambert E, Peterka C, Edilson Lima F, Carvalho Maia L, Lucena Cruz C, Maciele B, Vasconcelos M, Machado M, Augusto Figueira E, Alcirley Balieiro A, Batista Pereira D, Lacerda M.
    Lancet Infect Dis; 2024 Jun 01; 24(6):629-638. PubMed ID: 38452779
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malaria.
    Walsh DS, Eamsila C, Sasiprapha T, Sangkharomya S, Khaewsathien P, Supakalin P, Tang DB, Jarasrumgsichol P, Cherdchu C, Edstein MD, Rieckmann KH, Brewer TG.
    J Infect Dis; 2004 Oct 15; 190(8):1456-63. PubMed ID: 15378438
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malaria.
    Sharma R, Sharma H, Jones S, Borghini-Fuhrer I, Domingo GJ, Gibson RA, Rolfe K, Tan L, Fiţa IG, Chen C, Bird P, Pingle A, Duparc S.
    Malar J; 2024 May 13; 23(1):145. PubMed ID: 38741094
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prevention of Plasmodium vivax malaria recurrence: efficacy of the standard total dose of primaquine administered over 3 days.
    Carmona-Fonseca J, Maestre A.
    Acta Trop; 2009 Nov 13; 112(2):188-92. PubMed ID: 19653988
    [Abstract] [Full Text] [Related]

  • 15. Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand.
    Vijaykadga S, Rojanawatsirivej C, Congpoung K, Wilairatana P, Satimai W, Uaekowitchai C, Pumborplub B, Sittimongkol S, Pinyorattanachote A, Prigchoo P.
    Southeast Asian J Trop Med Public Health; 2004 Sep 13; 35(3):566-9. PubMed ID: 15689067
    [Abstract] [Full Text] [Related]

  • 16. Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria.
    Lacerda MVG, Llanos-Cuentas A, Krudsood S, Lon C, Saunders DL, Mohammed R, Yilma D, Batista Pereira D, Espino FEJ, Mia RZ, Chuquiyauri R, Val F, Casapía M, Monteiro WM, Brito MAM, Costa MRF, Buathong N, Noedl H, Diro E, Getie S, Wubie KM, Abdissa A, Zeynudin A, Abebe C, Tada MS, Brand F, Beck HP, Angus B, Duparc S, Kleim JP, Kellam LM, Rousell VM, Jones SW, Hardaker E, Mohamed K, Clover DD, Fletcher K, Breton JJ, Ugwuegbulam CO, Green JA, Koh GCKW.
    N Engl J Med; 2019 Jan 17; 380(3):215-228. PubMed ID: 30650322
    [Abstract] [Full Text] [Related]

  • 17. Treatment of acute vivax malaria with tafenoquine.
    Nasveld P, Kitchener S.
    Trans R Soc Trop Med Hyg; 2005 Jan 17; 99(1):2-5. PubMed ID: 15550254
    [Abstract] [Full Text] [Related]

  • 18. A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria.
    Fukuda MM, Krudsood S, Mohamed K, Green JA, Warrasak S, Noedl H, Euswas A, Ittiverakul M, Buathong N, Sriwichai S, Miller RS, Ohrt C.
    PLoS One; 2017 Jan 17; 12(11):e0187376. PubMed ID: 29121061
    [Abstract] [Full Text] [Related]

  • 19. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
    Rodrigo C, Rajapakse S, Fernando D.
    Cochrane Database Syst Rev; 2020 Sep 06; 9(9):CD010458. PubMed ID: 32892362
    [Abstract] [Full Text] [Related]

  • 20. Studies on Plasmodium vivax relapse pattern in Kheda district, Gujarat.
    Srivastava HC, Sharma SK, Bhatt RM, Sharma VP.
    Indian J Malariol; 1996 Dec 06; 33(4):173-9. PubMed ID: 9125831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.